249 related items for PubMed ID: 9230238
1. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study.
Agertoft L, Pedersen S.
Eur Respir J; 1997 Jul; 10(7):1507-12. PubMed ID: 9230238
[Abstract] [Full Text] [Related]
2. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
Agertoft L, Pedersen S.
J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
[Abstract] [Full Text] [Related]
3. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[Abstract] [Full Text] [Related]
4. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
5. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
Clark DJ, Clark RA, Lipworth BJ.
Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
[Abstract] [Full Text] [Related]
6. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects.
Grove A, Allam C, McFarlane LC, McPhate G, Jackson CM, Lipworth BJ.
Br J Clin Pharmacol; 1994 Dec; 38(6):527-32. PubMed ID: 7888291
[Abstract] [Full Text] [Related]
7. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[Abstract] [Full Text] [Related]
8. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ, Grove A, Cargill RI, Lipworth BJ.
Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
[Abstract] [Full Text] [Related]
9. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
[Abstract] [Full Text] [Related]
10. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ, Clark DJ, McFarlane LC.
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[Abstract] [Full Text] [Related]
11. Assessment of the relative systemic potency of inhaled fluticasone and budesonide.
Boorsma M, Andersson N, Larsson P, Ullman A.
Eur Respir J; 1996 Jul; 9(7):1427-32. PubMed ID: 8836654
[Abstract] [Full Text] [Related]
12. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.
Grahnén A, Eckernäs SA, Brundin RM, Ling-Andersson A.
Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290
[Abstract] [Full Text] [Related]
13. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R.
Pulm Pharmacol Ther; 2005 Dec; 18(5):328-36. PubMed ID: 15939311
[Abstract] [Full Text] [Related]
14. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Lönnebo A, Johansson M, Eckernäs SA.
Eur J Clin Pharmacol; 1997 Dec; 52(4):261-7. PubMed ID: 9248762
[Abstract] [Full Text] [Related]
15. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ, Lipworth BJ.
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[Abstract] [Full Text] [Related]
16. Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate.
Wolthers OD, Pedersen S.
Arch Dis Child; 1993 May; 68(5):673-6. PubMed ID: 8323338
[Abstract] [Full Text] [Related]
17. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma.
Kuna P, Joubert JR, Greefhorst LA, Magnussen H.
Clin Ther; 2003 Aug; 25(8):2182-97. PubMed ID: 14512127
[Abstract] [Full Text] [Related]
18. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[Abstract] [Full Text] [Related]
19. Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate.
Agertoft L, Pedersen S.
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e199-205. PubMed ID: 19320851
[Abstract] [Full Text] [Related]
20. Fluticasone propionate in asthma: a long term dose comparison study.
Verona E, Petrov D, Cserhati E, Hofman J, Geppe N, Medley H, Hughes S.
Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
